Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03087487 · ClinicalTrials.gov registry record
Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation
A clinical trial of Nonvalvular Atrial Fibrillation, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 466,991
- Enrollment target
- 1
- Study location
NCT03087487: Completed study of Nonvalvular Atrial Fibrillation, sponsored by Bristol-Myers Squibb.
NCT03087487 is a study of Nonvalvular Atrial Fibrillation that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 466,991 participants, above the 15,894-participant average among 5 other Nonvalvular Atrial Fibrillation trials with a reported enrollment target (2838% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03087487, a study of Nonvalvular Atrial Fibrillation, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 466,991 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objectives of this study are to compare the risk of major bleeding and stroke/systemic embolism (SE) events among oral anticoagulant (OAC)-naïve non-valvular atrial fibrillation (NVAF) patients initiating OAC warfarin or apixaban or dabigatran or rivaroxaban treatment.
Conditions Studied
Study Locations (1)
Michigan
- Local Institution - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 466,991 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2023-03-08 |
What the finished NCT03087487 record still lists
NCT03087487 is an observational study that tracks outcomes without assigning an intervention. Its 466,991 participants enrollment target places it among the larger protocols in the corpus, above the 15,894-participant average among 5 other Nonvalvular Atrial Fibrillation trials with a reported enrollment target (2838% higher).
The record links to 1 condition, with Nonvalvular Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT03087487 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03087487 about?
NCT03087487 is a clinical study titled "Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation". The primary objectives of this study are to compare the risk of major bleeding and stroke/systemic embolism (SE) events among oral anticoagulant (OAC)-naïve non-valvular atrial fibrillation (NVAF) patients initiating OAC warfarin or apixaban or dabigatran or rivaroxaban treatment.
What is the current status of trial NCT03087487?
This trial is currently completed. The enrollment target is 466,991 participants. The study started on 2016-06-01. Estimated completion is 2023-03-08.
What conditions does trial NCT03087487 study?
This clinical trial studies the following conditions: Nonvalvular Atrial Fibrillation.
Who is sponsoring clinical trial NCT03087487?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03087487 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nonvalvular Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)
RECRUITING · NA
-
The CONFORMAL Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
-
Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
COMPLETED
-
Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065060 · 500,000 participants
Parkinson Progression Marker Initiative Online (PPMI Online)
- NCT06017687 · 500,000 participants · NA
Data Collection and Evaluation of OptiBP Under Investigational Use
- NCT06342375 · 425,000 participants · NA
Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
- NCT06934239 · 400,000 participants · Phase 4
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI